Le deficit en alpha-1 antitrypsine. Une indication de transplantation hepatique pediatriqueDe Roover, Arnaud ; Detry, Olivier ; Honore, Pierre et alin Revue Médicale de Liège (2001), 56(11), 753-8 Alpha-1-antitrypsin deficiency is the most common inborn error of metabolism leading to liver transplantation, and the second cause of liver transplantation in children after biliary atresia. The authors ... [more ▼] Alpha-1-antitrypsin deficiency is the most common inborn error of metabolism leading to liver transplantation, and the second cause of liver transplantation in children after biliary atresia. The authors report the case of a 6-year-old girl, who was suffering from end-stage liver disease secondary to alpha-1-antitrypsin deficiency. She was successfully treated by whole liver transplantation, the hepatic graft coming from a 3-year-old donor. Three months later she went back to school. The authors discuss the pathogenesis and the natural history of this frequent cause of liver transplantation in children. [less ▲] Detailed reference viewed: 105 (24 ULg) One year experience of the Belgian Liver Intestine Comittee (BLIC) intranet database; ; et al in Acta Gastro-Enterologica Belgica (2001, January), 64(1), 7 Detailed reference viewed: 19 (3 ULg) Liver transplantation for hepatitis B virus infection: improving long-term outcomesDetry, Olivier ; Delwaide, Jean ![]() in Medscape Transplantation (2001) Detailed reference viewed: 10 (5 ULg) Comment je traite une ascite; Delwaide, Jean ; Detry, Olivier et alin Revue Médicale de Liège (2001), 56(12), 809-815 Ascites is the most common of the major complications of cirrhosis. The initial evaluation of a patient with ascites should include a history, physical evaluation and some investigations. Treatment should ... [more ▼] Ascites is the most common of the major complications of cirrhosis. The initial evaluation of a patient with ascites should include a history, physical evaluation and some investigations. Treatment should consist of treating the underlying liver disease, sodium restricted diet (2 g of Na+/day) and diuretics. This regimen is effective in 90 % of patients. The treatment options for the diuretic-resistant patients include serial therapeutic paracentesis, peritoneovenous shunting, TIPSand liver transplantation. The treatment and prophylaxis of spontaneous bacterial peritonitis which is a frequent and severe complication in cirrhotic patients with ascites is also important. The differential diagnosis with secondary bacterial peritonitisis is essential because the latter usually does not resolve unless patients are surgically treated. [less ▲] Detailed reference viewed: 32 (1 ULg) Factors inftuencing ribavirin-induced hemolysis; ; et al in Journal of Hepatology (2001), 34 BackgroundlAims: One of the major side eft'ects of the combination therapy for chronic hepatitis C is ribavirininduced hemolytic anemia. Little is known about variables inftuencing tbis anemia. Our study ... [more ▼] BackgroundlAims: One of the major side eft'ects of the combination therapy for chronic hepatitis C is ribavirininduced hemolytic anemia. Little is known about variables inftuencing tbis anemia. Our study tried to search for these variables in a large group of patients with hepatitis C treated with the combination therapy. Methods: Two hundred and forty-four patients chronically infected with the hepatitis C virus were treated either with induction treatment (daily dose ofinterferon) or with a standard treatment (interferon thrice weekly). Both groups received 1000-1200 mg of ribavirin from week 4 until the end of the treatment. The drop in hemoglobin level was defined as the dift'erence between the pretreatment hemoglobin level and the hemoglobin level at week 8. Seventeen variables which could possibly influencê'this drop in hemoglobin level were examined. Results: After multivariate analysis, the drop in hemoglobin level was only significant influenced by pretreatment platelet level, treatment and haptoglobin phenotype. The ribavirin dose did not influence the drop in hemoglobin level or the early virological response. Conclusions: Ribavirin-induced hemolysis is inftuenced by the pretreatment platelet level, the administered amount of a-interferon and the haptoglobin phenotype. A careful search for the minimal dose of ribavirin needed in combination treatment is necessary. [less ▲] Detailed reference viewed: 20 (0 ULg) Clinical biliary complications after adult liver transplantation: a prospective studyDetry, Olivier ; Maweja, Sylvie ; Delwaide, Jean et alin Acta Gastro-Enterologica Belgica (2000, March), 63(1), 56 Detailed reference viewed: 14 (5 ULg) L'image du mois. Thrombose de la veine porte; Delwaide, Jean ; Boverie, Jacques ![]() in Revue Médicale de Liège (2000), 55(8), 761-762 Detailed reference viewed: 11 (3 ULg) Evidence-Based Medicine: traitement de l'hépatite chronique C. GLEVHE. Groupe Liégeois d'Etude des Virus Hépatotropes.Delwaide, Jean ; Gerard, Christiane ; Belaiche, Jacques et alin Revue Médicale de Liège (2000), 55(5), 337-340 The Hepatitis C virus (HCV) infects nearly 170 million people in the world. The major characteristic of virus C is its tendency to chronicity in more than 85% of cases. Generally asymptomatic, HCV ... [more ▼] The Hepatitis C virus (HCV) infects nearly 170 million people in the world. The major characteristic of virus C is its tendency to chronicity in more than 85% of cases. Generally asymptomatic, HCV infection may also evolve with time to cirrhosis and hepatocellular carcinoma. During the last few years, HCV-related end-stage cirrhosis has become the first cause of liver transplantation. In 10 years only, very significant progress has been made in the knowledge of the virus, not only in the field of diagnosis but also in therapy. Several consensus conferences taking last discoveries into account have been organized in order to promote recommendations useful for the management of hepatitis C patients. The aim of this short overview is to summarize practical recommendations that emerged recently from consensus meetings. [less ▲] Detailed reference viewed: 32 (3 ULg) Chronic hepatitis B therapy with lamivudine in clinical practice - Summary of the discussion; Delwaide, Jean ; et alin Acta Gastro-Enterologica Belgica (2000), 63(4), 357-358 Detailed reference viewed: 5 (0 ULg) Hépatites C sporadiques. Risque iatrogène non négligeableDelwaide, Jean ![]() in Interface (2000), 6 On estime à plus de 150 millions le nombre d'individus infectés par le virus de l'hépatite C dans le monde. En Belgique, cette prévalence est estimée à 10/0, et la plupart des nouvelles contaminations se ... [more ▼] On estime à plus de 150 millions le nombre d'individus infectés par le virus de l'hépatite C dans le monde. En Belgique, cette prévalence est estimée à 10/0, et la plupart des nouvelles contaminations se retrouvent chez les toxicomanes utilisant des drogues intraveineuses. Les transmissions en milieu hospitalier pourraient cependant rendre compte d'une part non négligeable des hépatites C dites «sporadiques», dont le mode de transmission n'est jusqu'ici pas élucidé. [less ▲] Detailed reference viewed: 35 (2 ULg) Acute pancreatitis attributed to the use of interferon alfa-2b; ; et al in Gastroenterology (2000), 119(1), 230-233 Two patients experienced episodes of acute pancreatitis shortly after starting treatment with interferon alfa-2b (IFN-alpha) for a chronic hepatitis C infection. The first patient was a 40-year-old man ... [more ▼] Two patients experienced episodes of acute pancreatitis shortly after starting treatment with interferon alfa-2b (IFN-alpha) for a chronic hepatitis C infection. The first patient was a 40-year-old man who developed acute pancreatitis after 15 weeks of treatment with 3 MU IFN-alpha subcutaneously (SC) 3 times weekly and 1200 mg ribavirin. After disappearance of symptoms and normalization of laboratory values, oral intake of solid foods and IFN-alpha therapy were restarted. Within hours, a relapse of acute pancreatitis occurred. A rechallenge with IFN-alpha 4 days later was followed by a prompt increase in serum lipase level, and IFN-alpha therapy was discontinued. The second patient was a 38-year-old man who developed acute pancreatitis 2 hours after SC administration of 5 MU IFN-alpha. Ultrasound endoscopy showed sludge in the gallbladder. The patient was rechallenged 5 weeks later with 3 MU IFN-alpha SC. Although serum amylase and lipase levels increased after readministration of IFN-alpha, treatment was continued. The patient was readmitted 2 weeks later with severe abdominal pain, and IFN-alpha administration was discontinued. Considering the temporal relationship between the start of IFN-alpha treatment and development of acute pancreatitis, the absence of other clear etiologic factors for acute pancreatitis, disappearance of symptoms after discontinuation of IFN-alpha, and positive reactions to rechallenge, IFN-alpha is the most probable cause for development of acute pancreatitis in these patients. [less ▲] Detailed reference viewed: 13 (1 ULg) Treatment of acute hepatitis C with interferon alpha 2b prevents chronicity.Delwaide, Jean ; ; Gerard, Christiane et alin Gut (2000), 47(3), 14 Detailed reference viewed: 8 (0 ULg) Périartérite noueuse en relation avec une hépatite B; Delwaide, Jean ; et alin Revue Médicale de Liège (1999), 54(1), 921-924 A 66-year-old man was hospitalized for asthenia, weight loss, fever and chills. A polyarteritis nodosa associated with hepatitis B virus infection in a replicative phase was diagnosed. Etiology ... [more ▼] A 66-year-old man was hospitalized for asthenia, weight loss, fever and chills. A polyarteritis nodosa associated with hepatitis B virus infection in a replicative phase was diagnosed. Etiology, physiopathology, and clinical characteristics of hepatitis B virus-related polyarteritis nodosa will be reviewed, as well as the effectiveness of therapy combining corticosteroids, interferon alpha and plasma exchanges. [less ▲] Detailed reference viewed: 31 (2 ULg) Has disinfection of endoscopes by automatic machines become obligatory?Delwaide, Jean ; ; et alin Revue Médicale de Bruxelles (1999), 20(1), 49-50 Detailed reference viewed: 1 (0 ULg) Liver transplantation in a Jehovah's witnessDetry, Olivier ; Honoré, Pierre ; Delwaide, Jean et alin Lancet (1999), 353 Detailed reference viewed: 33 (12 ULg) La transmission du virus de l’hépatite C en milieu hospitalierDelwaide, Jean ; Gerard, Christiane ; Belaiche, Jacques et alin Médecine et Hygiène (1999), 57 Detailed reference viewed: 28 (8 ULg) Hepatitis C virus transmission following invasive medical proceduresDelwaide, Jean ; Gerard, Christiane ; Vaira, Dolorès et alin Journal of Internal Medicine (1999), 245(1), 107-108 Detailed reference viewed: 54 (6 ULg) La desinfection des endoscopes par machines automatiques est-elle devenue obligatoire?Delwaide, Jean ; ; et alin Revue Médicale de Bruxelles (1999), 20(1), 49-50 Detailed reference viewed: 23 (6 ULg) Prevalence of hepatitis G virus in a haemodialysis unitLamproye, Anne ; Delwaide, Jean ; Vaira, Dolorès et alin Acta Gastro-Enterologica Belgica (1999), 62(1), 13-15 Background : Recently, a novel blood-borne virus has been identified and named hepatitis G virus. Transfusion is the main route of transmission. It is known that patients on maintenance dialysis are more ... [more ▼] Background : Recently, a novel blood-borne virus has been identified and named hepatitis G virus. Transfusion is the main route of transmission. It is known that patients on maintenance dialysis are more susceptible to infections with parenterally-transmitted viruses than the general population. The aim of the present study was to determine the prevalence of hepatitis G infection in a Belgian dialysis unit. Methods: The entire population of our dialysis unit (82 patients) was tested for the presence of hepatitis G virus (HGV) by reverse transcriptase polymerase chain reaction. History of transfusion or renal transplantation coinfections with hepatitis B and C viruses, and serum aminotransferase levels were also tested. Results: Thirteen patients (16%) were found positive for HGV-RNA. Among these patients, 69.2% were infected by the G virus alone, 15.4% were coinfected with B virus, and 15.4% with C virus. All but one patient had a history of transfusion. Ten of the thirteen infected patients (77%) had normal aminotransferase (< 30 UI/l). Three patients had elevated aminotransferase levels (23%); one was coinfected with B virus, one with C virus, and the last one had a diabetes-induced fatty liver infiltration. No liver biopsies were performed. Conclusions :It is concluded that infection with C virus is common among dialyzed patients. This high rate of infection could be related to previous transfusions, but may as well be due to nosocomial transmission. In our series, at least one patient has been contaminated by another road than transplantation or transfusion. Finally, it does not appear clearly that chronic infection with hepatitis G virus induces Liver disease, as defined by elevated aminotransferase level. [less ▲] Detailed reference viewed: 94 (9 ULg) Hépatite à virus G: mythe ou réalité? VHG/GBV-C: diagnostic, épidémiologie, risque transfusionnel et pathogénicitéGerard, Christiane ; Vaira, Dolorès ; Delwaide, Jean et alin Revue Médicale de Liège (1998), 53(9), 524-528 The recently discovered G virus (also called either GBV-C or HGV) is transmitted by blood transfusion as well as by sexual intercourse. The global prevalence of GBV-C is high, not only in those groups ... [more ▼] The recently discovered G virus (also called either GBV-C or HGV) is transmitted by blood transfusion as well as by sexual intercourse. The global prevalence of GBV-C is high, not only in those groups classically known to be exposed to parenteral risks (i.v. drug users, polytransfused patients), but also in the blood donors population. The diagnosis of active infection lies on the search of GBV-C RNA by Polymerase Chain Reaction whereas that of resolved (past) infection lies on the presence of specific antibodies. Till now, it has not been possible to correlate convincingly the presence of GBV-C RNA with any acute or chronic hepatopathy. On the contrary, a lot of arguments tend to suggest that the GBV-C is not pathogenic for the liver, although some modes of transmission are common with those of other (known and probably not known) hepatotropic viruses. According to the actual knowledge of the consequences of GBV-C infection, it appears as non relevant to instaure a systematic screening of this new virus in blood donors. [less ▲] Detailed reference viewed: 21 (2 ULg) |
||